Phototherapy

Scalp psoriasis improvement was maintained with long-term tildrakizumab treatment in what researchers said is the first “dedicated trial” to demonstrate sustainable efficacy of an anti-interleukin-23 inhibitor for the condition.

Published results showed “Latine” patients with psoriasis in the U.S. have unique experiences with their disease and subsequent care, including lack of awareness about psoriasis, workplace difficulties and a preference for biologic treatment.

The Janus kinase inhibitor baricitinib, in combination with narrowband ultraviolet B therapy, improved vitiligo, according to a study.

Home-based phototherapy proved effective for the treatment of plaque and guttate psoriasis across skin types, providing a convenient therapy method for patients, according to a study.

Otezla is now available in the U.S. for the treatment of moderate to severe plaque psoriasis in children and adolescents aged 6 years and older, Amgen announced in a press release.

The first 100 patients have been enrolled in a clinical trial investigating a novel light therapy device intended to treat individuals with Parkinson’s disease, according to the manufacturer.

SAN DIEGO — In patients with active nonsegmental vitiligo, ritlecitinib monotherapy or paired with twice weekly narrowband ultraviolet B phototherapy improved facial and total body repigmentation, according to a speaker here.

SAN DIEGO — In this video perspective, Healio Dermatology Chief Medical Editor Joel M. Gelfand, MD, MSCE, discusses highlights from the LITE study on home vs. office-based phototherapy for plaque or guttate psoriasis.